AIM ImmunoTech Inc.
AIM
$0.26
$0.00-1.83%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 94.00K | 88.00K | 112.00K | 121.00K | 146.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 94.00K | 88.00K | 112.00K | 121.00K | 146.00K |
| Cost of Revenue | 122.00K | 128.00K | 95.00K | 35.00K | 33.00K |
| Gross Profit | -28.00K | -40.00K | 17.00K | 86.00K | 113.00K |
| SG&A Expenses | 7.08M | 7.87M | 10.26M | 11.54M | 12.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.37M | 11.75M | 14.68M | 16.73M | 17.80M |
| Operating Income | -10.27M | -11.66M | -14.57M | -16.61M | -17.66M |
| Income Before Tax | -13.28M | -13.96M | -15.75M | -16.17M | -15.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.28 | -13.96 | -15.75 | -16.17 | -15.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.28M | -13.96M | -15.75M | -16.17M | -15.21M |
| EBIT | -10.27M | -11.66M | -14.57M | -16.61M | -17.66M |
| EBITDA | -10.08M | -11.45M | -14.34M | -16.37M | -17.41M |
| EPS Basic | -7.39 | -11.96 | -19.86 | -24.70 | -24.49 |
| Normalized Basic EPS | -5.52 | -8.40 | -13.15 | -15.56 | -15.34 |
| EPS Diluted | -7.39 | -11.96 | -19.86 | -24.70 | -24.49 |
| Normalized Diluted EPS | -5.52 | -8.40 | -13.15 | -15.56 | -15.34 |
| Average Basic Shares Outstanding | 10.09M | 6.44M | 4.20M | 2.68M | 2.45M |
| Average Diluted Shares Outstanding | 10.09M | 6.44M | 4.20M | 2.68M | 2.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |